← Back to patent-cliff list
Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside
Tier C — Watch / tradeAlpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Not applicable
Indications (approved)：Lung adenocarcinoma
Regional status
US
Phase II
2023-01-19
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside?
Approved indications include: Lung adenocarcinoma.
When does the Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside patent expire?
No public expiry year is available for Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside yet; this page updates once verified.
How do I get a quote for Alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03